0
Eidos Therapeutics, Inc. Banner Image

Eidos Therapeutics, Inc.

  • Ticker EIDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eidos Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Eidos is developing acoramidis, a potentially disease-modifying therapy for the treatment of ATTR.
Eidos Therapeutics, Inc.

Most Recent Annual Report

Eidos Therapeutics, Inc.
MOST RECENT 2019 Annual Report and Form 10K

Older/Archived Annual Reports